SEC Form D · filed February 13, 2017
HEMISPHERX BIOPHARMA INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Thomas K. Equels · Philadelphia, PAExec · DirectorStewart W. Appelrouth · Philadelphia, PADirectorDavid K. Strayer · Philadelphia, PAExecWayne K. Springate · Philadelphia, PAExecWilliam K. Mitchell · Philadelphia, PADirectorAdam K. Pascale · Philadelphia, PAExecPeter W. Rodino · Philadelphia, PAExecDavid A. Witkin · Redondo Beach, CAExecRandall M. Stevens · BOSTON, MAExecArnold Oronsky · BOSTON, MAExec · DirectorMark Hanson · Chicago, ILDirectorChang K. Kim · Dania Beach, FLExecDenise A. Archer · Grand Cayman, Cayman IslandsExecLalitendu K. Panda · Dania Beach, FLDirectorThomas W. Horner · Atlanta, GAExec · DirectorRobert N. Longo · Atlanta, GAExecJeffrey S. Meister · Newport Beach, CADirectorNicholas D. Tannura · Newport Beach, CADirectorJulia S. Pence · Newport Beach, CAExecCraig A. Leupold · Newport Beach, CAExecAdriel Lares · San Francisco, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗